Skip to content

Comparison of Photobiomodulation and Moist Heat Therapy for Reducing Jaw Pain in Temporomandibular Disorders

Study to evaluate and compare the effect of photobiomodulation and moist heat therapy in management of Temporomandibular Disorders - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102457
Enrollment
36
Registered
2026-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M95-M95- Other disorders of the musculoskeletal system and connective tissue

Interventions

Intervention1: STUDY TO EVALUATE AND COMPARE THE EFFECT OF PHOTOBIOMODULATION AND MOIST HEAT THERAPY IN MANAGEMENT OF TEMPOROMANDIBULAR DISORDERS: 1 Source of data This In-vivo study will be conducted

Sponsors

DrADYASHA SAHU
Lead Sponsor
DR GANARAJ SHETTY
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with Temporomandibular Disorder as per RDC OR TMD criteria .Pain duration of more than 3 months.Baseline pain intensity MORE THAN OR EQUAL TO 4 on a 10 cm Visual Analogue Scale

Exclusion criteria

Exclusion criteria: 1. Patient with history of trauma, surgery, or systemic inflammatory arthritis affecting the TMJ. 2. Contraindications to laser therapy (pregnancy, photosensitivity) or heat therapy (sensory deficits, skin infection). 3. Patients receiving corticosteroid injections or other invasive TMD treatments in the preceding 3 months. 4. Patients on muscle relaxants or anticoagulant therapy. 5. Patients with radiographic evidence of TMJ bony pathology.

Design outcomes

Primary

MeasureTime frame
changes in pain, function, and quality-of-life scores using standardized scales. Data will be analyzed to determine treatment effectivenessTimepoint: Day 0, Week 2, Week 4

Secondary

MeasureTime frame
Secondary outcomes will assess patient satisfaction, treatment acceptability, and any adverse effects. Additional measures such as range of motion and symptom recurrence will also be recordedTimepoint: 4 week, 6 week, 8 week

Countries

India

Contacts

Public ContactDr. ADYASHA SAHU

NITTE ( DEEMED TO BE UNIVERSITY)

drganarajshetty@nitte.edu.in9880541104

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026